Lianhua Qingwen is caught in controversy, and the market value of Yiling Pharmaceutical has evaporated by 26 billion in two weeks | CCP epidemic | Stock price
[The Epoch Times, December 27, 2022](Interview and report by reporter Zhang Zhongyuan from the Epoch Times special department)series of flowersIt is a so-called drug to treat the CCP virus (new coronavirus) approved by the Chinese Drug Administration, but it has recently been involved in controversies such as liver damage. Its companyYiling Pharmaceuticalshare priceThe market value … Read more